Marijuana Business Magazine March 2020

Marijuana Business Magazine | March 2020 30 European Commission Proposes EU vote on WHO Cannabis Scheduling Recommendations In advance of the March session of the United Nations Commission on Narcotic Drugs, the European Union’s executive branch has proposed that EU-member nations vote in favor of certain World Health Organization (WHO) cannabis-scheduling recommendations. The supported changes include: • Removing cannabis and cannabis resin from Schedule IV, which effectively recognizes that cannabis and cannabis resin have medical value. • Adding dronabinol (delta-9 tetrahydrocannabinol) and tetrahydrocannabinol (isomers of delta-9 tetrahydrocannabinol) to Schedule I. Canadian Cannabis Firms Eligible for Government Funding Medical cannabis companies based in Canada are eligible to receive financial aid and other forms of support from the federal government to explore international business opportunities. The “full menu” of the Trade Commissioner Service, which is funded by the government, may be IndustryDevelopments | International & State National & International News Countries included have passed legislation at the federal level and must fulfill at least one of the following criteria: • Cultivation, manufacture or sale of medical and/or recreational cannabis allowed. • Doctors can prescribe medical cannabis. • Import and/or export of medical cannabis allowed. High: Countries at the forefront of the global industry. Frameworks are established, and adoption is well underway. Medium: Implementation has begun but is still limited or restricted; lots of room for the market to develop. Low: Legislation has been passed, but implementation is very limited or nonexistent. Decriminalization is not included. MAP LEGEND High level of medical development/implementation Medium level of medical development/implementation Low level of medical development/implementation Other - federally illegal but unique circumstances Recreational